» Articles » PMID: 18497458

Population-based Case-control Study of Renin-angiotensin System Genes Polymorphisms and Hypertension Among Hispanics

Overview
Journal Hypertens Res
Date 2008 May 24
PMID 18497458
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of polymorphisms of the RAS genes on the incidence of hypertension seems to be population-dependent. We studied the effects of the angiotensinogen T174M and M235T, angiotensin converting enzyme insertion/deletion (ACE I/D), and angiotensin II receptor 1 (AT1R) A1166C gene polymorphisms on the risk of hypertension among Hispanics. We selected all cases (n=256) and 257 age and sex group-matched controls from a random sample of free living Colombians (n=2,989). Logistic regression was used to estimate the independent effect of each polymorphism. All polymorphisms were in Hardy-Weinberg equilibrium in controls, with the exception of M235T, which showed a small excess of heterozygotes (p=0.005; disequilibrium coefficient, D=-0.0264). After adjustment for age, sex, body mass index, race, physical activity, family history of hypertension and cardiovascular disease, and other polymorphisms, subjects with the ACE DD genotype were 1.56 times (95% confidence interval [CI]: 1.05, 2.33) more likely to be hypertensive than carriers of the I allele (p=0.03). Also, adjusted systolic and diastolic blood pressure were 4.58 (95% CI: -0.39, 9.56) and 3.32 (95% CI: 0.78, 5.86) mmHg higher in DD homozygous individuals than in carriers of the I allele, respectively. Approximately 15% of the cases of hypertension in this population could be attributed to carriage of the DD genotype. None of the other polymorphisms was associated with either hypertension or blood pressure level. In conclusion, the ACE DD genotype appears to be an independent risk factor for development of hypertension and may explain a significant fraction of incident cases among Hispanics.

Citing Articles

The frequency of the ACE I/D polymorphism in South America: a systematic review and meta-analysis.

Trevisano R, Matias H, de Jesus Teani T, Silvino V, Ferreira C, Dos Santos M Mol Cell Biochem. 2024; 479(11):2955-2972.

PMID: 38310174 DOI: 10.1007/s11010-023-04923-9.


Association Between -AGT and -ACE Polymorphisms and Carotid Atheromatosis in Hypertensive Patients: A Cross-Sectional Study.

Mocan O, Radulescu D, Buzdugan E, Cozma A, Leucuta D, Procopciuc L In Vivo. 2020; 34(5):2811-2819.

PMID: 32871819 PMC: 7652438. DOI: 10.21873/invivo.12107.


Relationship of renin-angiotensin system polymorphisms with ambulatory and central blood pressure in patients with hypertension.

Han W, Sun N, Chen L, Jiang S, Chen Y, Li M J Clin Hypertens (Greenwich). 2017; 19(11):1081-1087.

PMID: 28834200 PMC: 8031105. DOI: 10.1111/jch.13061.


Age differences in arterial and venous extra-cerebral blood flow in healthy adults: contributions of vascular risk factors and genetic variants.

Raz N, Daugherty A, Sethi S, Arshad M, Haacke E Brain Struct Funct. 2017; 222(6):2641-2653.

PMID: 28120105 PMC: 6548544. DOI: 10.1007/s00429-016-1362-2.


Relationship among angiotensin-converting enzyme polymorphism, cardiovascular risk, and osteoporotic fractures.

Briongos-Figuero L, Cuadrado-Medina F, Abad-Manteca L, Vega-Tejedor G, Pineda-Alonso M, Perez-Castrillon J Eur J Rheumatol. 2016; 3(1):10-12.

PMID: 27708962 PMC: 5042267. DOI: 10.5152/eurjrheum.2015.150040.